๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Does osteoporosis therapy invalidate FRAX for fracture prediction?

โœ Scribed by William D Leslie; Lisa M Lix; Helena Johansson; Anders Oden; Eugene McCloskey; John A Kanis; for the Manitoba Bone Density Program


Book ID
112118099
Publisher
American Society for Bone and Mineral Research
Year
2012
Tongue
English
Weight
262 KB
Volume
27
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


WHO absolute fracture risk models (FRAX)
โœ Teresa A Hillier; Jane A Cauley; Joanne H Rizzo; Kathryn L Pedula; Kristine E En ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 232 KB ๐Ÿ‘ 1 views

## Abstract Bone mineral density (BMD) is a strong predictor of fracture, yet most fractures occur in women without osteoporosis by BMD criteria. To improve fracture risk prediction, the World Health Organization recently developed a countryโ€specific fracture risk index of clinical risk factors (FR

Trabecular stress fractures during fluor
โœ C. M. Schnitzler; L. Solomon ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 861 KB

Joint pain and swelling in patients on fluoride therapy are generally attributed to rheumatic phenomena; however, their occurrence exclusively in the lower limbs suggests a mechanical cause. Eight patients receiving daily doses of sodium fluoride 1.09 mg/kg, elemental calcium I gin, and vitamin D 10